These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34234074)

  • 1. Chronotropic Assessment in Patients with Constrictive Pericarditis.
    Imamura T; Narang N; Besser S; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):811-815. PubMed ID: 34234074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
    Imamura T; Hori M; Narang N; Besser S; Kinugawa K
    Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
    Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of Heart Rate in Patients with Left Ventricular Assist Devices.
    Imamura T; Kinugawa K; Narang N; Nishida H; Pinney S; Jeevanandam V; Ota T
    Int Heart J; 2022; 63(1):56-61. PubMed ID: 35095077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Heart Rate Modulation Using Ivabradine.
    Imamura T; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):717-721. PubMed ID: 34276025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial.
    Böhm M; Swedberg K; Komajda M; Borer JS; Ford I; Dubost-Brama A; Lerebours G; Tavazzi L;
    Lancet; 2010 Sep; 376(9744):886-94. PubMed ID: 20801495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis of heart failure treated with digoxin or with ivabradine: A cohort study in the community.
    Guzman M; Gomez R; Romero SP; Aranda R; Andrey JL; Pedrosa MJ; Egido J; Gomez F
    Int J Clin Pract; 2018 Nov; 72(11):e13217. PubMed ID: 30248211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Reducing Heart Rate on Outcomes in Patients With Reduced Ejection Fraction.
    Lan WR; Lin SI; Liao FC; Chang HY; Tsai CT; Wu YJ; Liu PY; Chen CH; Lee YH
    Am J Cardiol; 2021 Jul; 150():77-81. PubMed ID: 34006371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety analysis of ivabradine hydrochloride treatment of Chinese patients with chronic heart failure: subgroup analysis of Chinese patients in the SHIFT study].
    Hu DY; Huang DJ; Yuan ZY; Zhao RP; Yan XW; Wang MH;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):190-197. PubMed ID: 28316174
    [No Abstract]   [Full Text] [Related]  

  • 10. The implication of optimal heart rate in patients with systolic dysfunction following TAVR.
    Imamura T; Tanaka S; Ushijima R; Sobajima M; Fukuda N; Ueno H; Besser S; Kinugawa K
    J Card Surg; 2021 Apr; 36(4):1328-1333. PubMed ID: 33538004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of optimal heart rate on left ventricular reverse remodeling and functional improvement in patients with systolic heart failure.
    Izumida T; Imamura T; Ueno Y; Tanaka S; Kataoka N; Nakamura M; Kinugawa K
    Heart Vessels; 2021 Nov; 36(11):1688-1693. PubMed ID: 33956182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of pericardial delayed hyperenhancement predicts clinical improvement in patients with constrictive pericarditis treated with anti-inflammatory therapy.
    Cremer PC; Tariq MU; Karwa A; Alraies MC; Benatti R; Schuster A; Agarwal S; Flamm SD; Kwon DH; Klein AL
    Circ Cardiovasc Imaging; 2015 May; 8(5):. PubMed ID: 25904576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Heart Rate and Prognosis in Patients with Cardiac Amyloidosis.
    Izumida T; Imamura T; Nakamura M; Kinugawa K
    J Cardiovasc Dev Dis; 2021 Dec; 8(12):. PubMed ID: 34940536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Doppler echocardiography-guided ivabradine therapy.
    Izumida T; Imamura T; Kinugawa K
    Heart Vessels; 2023 Jan; 38(1):49-55. PubMed ID: 35789418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcific constrictive pericarditis in a patient presenting with right heart failure.
    Can I; Kerimoğlu U; Ozdemir K
    Turk Kardiyol Dern Ars; 2008 Sep; 36(6):397-9. PubMed ID: 19155644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of Severe Right-Sided Heart Failure Due to Postoperative Constrictive Pericarditis With Tolvaptan.
    Kanaya M; Matsushita K; Inami T; Yamasaki S; Mizumi S; Minamishima T; Goda A; Ueda A; Sakata K; Satoh T; Yoshino H
    Am J Ther; 2016; 23(1):e264-7. PubMed ID: 25343308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis.
    Andreis A; Imazio M; Giustetto C; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1561-1565. PubMed ID: 32868281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic time intervals in constrictive pericarditis. A study before and after digitalis.
    Bhatia ML; Manjuran RJ
    Br Heart J; 1975 Nov; 37(11):1176-83. PubMed ID: 1191433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.